Jade Biosciences Inc

JBIONASDAQ · USD
14.35USD0.00 (-0.49%)
2110

Jade Biosciences Inc (JBIO) Covered Calls

As of September 25, 2026, JBIO has 6 covered call opportunities in the coming three months. Return ranges from 2.7 to 25.1% until expiration. Annualized return ranges from 16.7 to 96.0%. The nearest expiration is October 16, 2026. Maximum potential profit is $369.

Read more

Running JBIO covered calls helps you generate consistent income from Jade Biosciences Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Jade Biosciences Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best JBIO covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if JBIO stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling JBIO covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Jade Biosciences Inc covered call is worth writing.

Jade Biosciences, Inc. is a biotechnology company focused on developing best-in-class therapies to address critical unmet needs in autoimmune diseases. Their lead asset, JADE-001, targets the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for the treatment of immunoglobulin A (IgA) nephropathy. JADE-001 is anticipated to enter clinical trials in the second half of 2025, with initial data expected in the first half of 2026. The company's pipeline also includes two preclinical antibody programs, JADE-002 and JADE-003.

Income-focused investors, long-term JBIO holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling JBIO covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Jade Biosciences Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile21.43% Subdued
  • Market cap (M$)913
  • 52 weeks high-48.75%
  • 52 weeks low75.86%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$49.89
    247.67% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-12
  • P/E—
  • Future P/E—
  • EPS (ttm)-2.61
  • EPS growth next 5 years3.74%

As of September 25, 2026

2026-10-162315.001.970.601.7089.006.0596.02-4.08+0.5101.10
2027-02-1914917.5018.970.304.90309.0021.0151.46-2.04+0.5104.60
2027-05-2124017.5018.970.904.90369.0025.0838.15-6.12+0.53254.00
2027-02-1914915.001.971.154.90144.009.7923.98-7.82+0.6003.75
2027-05-2124015.001.971.755.50204.0013.8721.09-11.90+0.6303.75
2026-11-205815.001.970.104.9039.002.6516.68-0.68+0.5814.80

As of September 25, 2026

Sell covered calls with the data behind you

Find the best JBIO covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial